As weight loss drugs boom in popularity, some companies are focusing their sights on therapies for muscle loss prevention, a common side effect of weight loss treatments. In recent years, blockbuster ...

Building on the success of the anti-Myostatin program, iBio Launches New Program Featuring Myostatin + Activin A Bispecific Antibody Designed to Promote Weight Loss, Prevent Muscle Loss and Weight ...

Peptidream Inc. has released promising results from preclinical testing of its oral myostatin inhibitors, administered in combination with semaglutide, in a mouse model of obesity.